Anticancer Drugs Compared to No Anticancer Drugs in Patients with Advanced Hepatobiliary Cancer: A Mapping Review and Evidence Gap Map

INTRODUCTION: Despite being commonly recommended, the impact of anticancer drugs (ACDs) on patient-important outcomes beyond survival for advanced hepatobiliary cancers (HBCs) may not have been sufficiently assessed. We aim to identify and map the evidence regarding ACDs versus best supportive care...

Descripción completa

Detalles Bibliográficos
Autores principales: Requeijo, Carolina, Bracchiglione, Javier, Meza, Nicolás, Acosta-Dighero, Roberto, Salazar, Josefina, Santero, Marilina, Meade, Adriana-G, Quintana, María Jesús, Rodríguez-Grijalva, Gerardo, Selva, Anna, Solà, Ivan, Urrútia, Gerard, Bonfill Cosp, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644842/
https://www.ncbi.nlm.nih.gov/pubmed/38025841
http://dx.doi.org/10.2147/CLEP.S431498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644842/
https://www.ncbi.nlm.nih.gov/pubmed/38025841
http://dx.doi.org/10.2147/CLEP.S431498

Ejemplares similares